JP2011525174A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011525174A5 JP2011525174A5 JP2011511802A JP2011511802A JP2011525174A5 JP 2011525174 A5 JP2011525174 A5 JP 2011525174A5 JP 2011511802 A JP2011511802 A JP 2011511802A JP 2011511802 A JP2011511802 A JP 2011511802A JP 2011525174 A5 JP2011525174 A5 JP 2011525174A5
- Authority
- JP
- Japan
- Prior art keywords
- kinesin
- hset
- meiotic
- activity
- meiotic kinesin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5759008P | 2008-05-30 | 2008-05-30 | |
| US61/057,590 | 2008-05-30 | ||
| PCT/US2009/045406 WO2009155025A1 (en) | 2008-05-30 | 2009-05-28 | Methods of treating a meiotic kinesin-associated disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015020184A Division JP6132409B2 (ja) | 2008-05-30 | 2015-02-04 | 減数分裂期キネシンに関連する疾患を治療する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011525174A JP2011525174A (ja) | 2011-09-15 |
| JP2011525174A5 true JP2011525174A5 (cg-RX-API-DMAC10.html) | 2012-07-12 |
| JP5735417B2 JP5735417B2 (ja) | 2015-06-17 |
Family
ID=41110533
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011511802A Expired - Fee Related JP5735417B2 (ja) | 2008-05-30 | 2009-05-28 | 減数分裂期キネシンに関連する疾患を治療する方法 |
| JP2015020184A Expired - Fee Related JP6132409B2 (ja) | 2008-05-30 | 2015-02-04 | 減数分裂期キネシンに関連する疾患を治療する方法 |
| JP2016108400A Expired - Fee Related JP6184556B2 (ja) | 2008-05-30 | 2016-05-31 | 減数分裂期キネシンに関連する疾患を治療する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015020184A Expired - Fee Related JP6132409B2 (ja) | 2008-05-30 | 2015-02-04 | 減数分裂期キネシンに関連する疾患を治療する方法 |
| JP2016108400A Expired - Fee Related JP6184556B2 (ja) | 2008-05-30 | 2016-05-31 | 減数分裂期キネシンに関連する疾患を治療する方法 |
Country Status (12)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9486449B2 (en) | 2007-10-09 | 2016-11-08 | Malka COHEN-ARMON | Cancer therapy |
| MX2010012931A (es) | 2008-05-30 | 2011-02-24 | Dana Farber Cancer Inst Inc | Metodos para tratar una enfermedad asociada con quinesina meiotica. |
| WO2013142817A2 (en) | 2012-03-23 | 2013-09-26 | Dennis Brown | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| US20150309031A2 (en) * | 2013-12-05 | 2015-10-29 | Novazoi Theranostics | Compositions and methods for prognosis and treatment of cancer |
| WO2015130953A1 (en) * | 2014-02-28 | 2015-09-03 | Novazoi Theranostics, Inc. | Method for determining the risk profile of neoplastic tissue |
| CN113456633A (zh) * | 2021-06-11 | 2021-10-01 | 广西医科大学 | 红海海绵素a在制备抗肺癌侵袭转移药物中的应用 |
| AU2023205435A1 (en) | 2022-01-10 | 2024-08-22 | Cancer Research Horizons | Substituted heterocycles as hset inhibitors |
| CN115327125A (zh) * | 2022-07-14 | 2022-11-11 | 宁波大学 | 一种蛋白质inf2在制备肝癌诊断标志物中的应用 |
| CN120265629A (zh) | 2022-11-07 | 2025-07-04 | 默克专利股份公司 | 被取代的双环和三环hset抑制剂 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US5374548A (en) | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
| MX9203291A (es) | 1985-06-26 | 1992-08-01 | Liposome Co Inc | Metodo para acoplamiento de liposomas. |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| AU4367700A (en) * | 1999-04-20 | 2000-11-02 | Cytokinetics, Inc. | Human kinesins and methods of producing and purifying human kinesins |
| US6410254B1 (en) * | 1999-05-18 | 2002-06-25 | Cytokinetics | Compositions and assays utilizing ADP or phosphate for detecting protein modulators |
| US7202051B1 (en) * | 1999-05-18 | 2007-04-10 | Cytokinetics, Inc. | Compositions and assays utilizing ADP or phosphate for detecting protein modulators |
| US7416856B2 (en) * | 1999-05-18 | 2008-08-26 | Cytokinetics, Inc. | High sensitivity assay for detection of nucleoside diphosphate production |
| US6743599B1 (en) * | 1999-05-18 | 2004-06-01 | Cytokinetics, Inc. | Compositions and assays utilizing ADP or phosphate for detecting protein modulators |
| WO2002078639A2 (en) | 2001-03-29 | 2002-10-10 | Bristol-Myers Squibb Company | A method of treating proliferative diseases using eg5 inhibitors |
| US20040009156A1 (en) * | 2001-10-12 | 2004-01-15 | Christoph Reinhard | Antisense therapy using oligonucleotides that target human kinesin genes for treatment of cancer |
| US7163927B2 (en) | 2002-05-23 | 2007-01-16 | Isis Pharmaceuticals, Inc. | Antisense modulation of kinesin-like 1 expression |
| US20050100508A1 (en) | 2003-11-12 | 2005-05-12 | Nichols M. J. | Methods for identifying drug combinations for the treatment of proliferative diseases |
| US20070026424A1 (en) * | 2005-04-15 | 2007-02-01 | Powell Charles A | Gene profiles correlating with histology and prognosis |
| AR062200A1 (es) | 2006-08-04 | 2008-10-22 | Aeterna Zentaris Gmbh | Derivados de antraceno y su uso para el tratamiento de emfermedades tumorales bengnas y malingnas |
| US20080051463A1 (en) * | 2006-08-04 | 2008-02-28 | Aeterna Zentaris Gmbh | Anthracene compounds and their use for treating benign and malignant tumor disorders |
| WO2008132752A2 (en) | 2007-05-01 | 2008-11-06 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Methods and kits for predicting cancer metastasis |
| MX2010012931A (es) | 2008-05-30 | 2011-02-24 | Dana Farber Cancer Inst Inc | Metodos para tratar una enfermedad asociada con quinesina meiotica. |
-
2009
- 2009-05-28 MX MX2010012931A patent/MX2010012931A/es not_active Application Discontinuation
- 2009-05-28 US US12/994,920 patent/US8629118B2/en active Active
- 2009-05-28 BR BRPI0912043-2A patent/BRPI0912043A2/pt not_active IP Right Cessation
- 2009-05-28 WO PCT/US2009/045406 patent/WO2009155025A1/en not_active Ceased
- 2009-05-28 EP EP09767337.0A patent/EP2315594B1/en active Active
- 2009-05-28 EA EA201071422A patent/EA201071422A1/ru unknown
- 2009-05-28 ES ES09767337.0T patent/ES2633930T3/es active Active
- 2009-05-28 CA CA 2725911 patent/CA2725911A1/en not_active Abandoned
- 2009-05-28 AU AU2009260527A patent/AU2009260527A1/en not_active Abandoned
- 2009-05-28 CN CN2009801299003A patent/CN102316877A/zh active Pending
- 2009-05-28 KR KR20107029850A patent/KR20110022000A/ko not_active Withdrawn
- 2009-05-28 JP JP2011511802A patent/JP5735417B2/ja not_active Expired - Fee Related
-
2013
- 2013-12-11 US US14/103,520 patent/US8962592B2/en not_active Expired - Fee Related
-
2015
- 2015-01-07 US US14/591,678 patent/US9645136B2/en not_active Expired - Fee Related
- 2015-02-04 JP JP2015020184A patent/JP6132409B2/ja not_active Expired - Fee Related
-
2016
- 2016-05-31 JP JP2016108400A patent/JP6184556B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bates et al. | Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T‐cell lymphoma | |
| Quint et al. | The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas | |
| Chan et al. | RETRACTED ARTICLE: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer | |
| Ebner et al. | Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference | |
| An et al. | Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells | |
| US12590162B2 (en) | Cancer treatment | |
| BR112019026484A2 (pt) | tinostamustina para uso no tratamento de leucemia prolinfocítica de células t | |
| EP2945646A1 (en) | Estrogen receptor inhibitors | |
| Li et al. | Curcumin suppresses the progression of gastric cancer by regulating circ_0056618/miR-194-5p axis | |
| Lee et al. | Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo | |
| CN109550051B (zh) | 组蛋白去甲基化酶kdm6a抑制剂在制备肥胖症治疗药物的用途 | |
| WO2019204399A1 (en) | Methods and compositions for treating cancer | |
| Tellenbach et al. | Combination of the novel RAF dimer inhibitor brimarafenib with the MEK inhibitor mirdametinib is effective against NRAS mutant melanoma | |
| Wolfson et al. | Enhancing FTS (Salirasib) efficiency via combinatorial treatment | |
| TWI522616B (zh) | 抗癌藥物之篩選方法及治療癌症之方法 | |
| KR101999476B1 (ko) | Alk 저해제에 내성을 획득한 eml4-alk 양성 비소세포폐암의 치료를 위한 약물 선택의 정보 제공 방법 | |
| Cai et al. | mTORC1 hyperactivation and resultant suppression of macroautophagy contribute to the induction of cardiomyocyte necroptosis by catecholamine surges | |
| US20170027955A1 (en) | Expression levels of bcl-xl, bcl2, bcl-w, and bad and cancer therapies | |
| Wu et al. | Adiponectin signals through Adiponectin Receptor 1 to reverse imatinib resistance in K562 human chronic myeloid leukemia cells | |
| US20220202804A1 (en) | Compositions and methods to treat cancer | |
| Wang et al. | BAP1 suppresses white adipose tissue browning and thermogenesis through deubiquitinating KDM1B | |
| WO2024254195A1 (en) | Methods for treating pancreatic cancer with a combination of des-methyl pateamine a and a class 1 hdac inhibitor | |
| WO2025189122A1 (en) | Method to prevent and treat cancer cachexia | |
| Telang et al. | 69 Essential role of inducible 6-phosphofructo-2-kinase in ras transformation | |
| KR20140096222A (ko) | 메트포르민을 유효 성분으로 함유하는 염증성 장 질환의 치료 및 예방용 약학 조성물 |